SPYRE THERAPEUTICS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
SPYRE THERAPEUTICS, INC. (SYRE) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 66.00 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-05
- SPYRE THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 66.00M shares, a 0.60% increase year-over-year.
- SPYRE THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 65.95M shares, a 1.36% increase year-over-year.
- SPYRE THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 65.79M shares, a 5.70% increase year-over-year.
- SPYRE THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 65.63M shares, a 23.97% increase year-over-year.
- SPYRE THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 65.74M shares, a 23.18% increase from fiscal 2020.
- SPYRE THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 53.37M shares, a 67.05% increase from fiscal 2019.
- SPYRE THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 31.95M shares, a 53.44% increase from fiscal 2018.
- SPYRE THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 20.82M shares, a 37.64% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 66.00M shares 10-Q · filed 2022-05-05 | 65.97M shares derived: average of 2 quarters · filed 2022-05-05 | 65.91M shares derived: average of 3 quarters · filed 2022-05-05 | 65.84M shares derived: average of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 65.95M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | 65.87M shares derived: average of 2 quarters · filed 2022-03-08 | 65.79M shares derived: average of 3 quarters · filed 2022-03-08 | 65.74M shares 10-K · filed 2022-03-08 |
| 2021-09-30 | 65.79M shares 10-Q · filed 2021-11-04 | 65.71M shares derived: average of 2 quarters · filed 2021-11-04 | 65.68M shares 10-Q · filed 2021-11-04 | 65.52M shares derived: average of 4 quarters · filed 2022-05-05 |
| 2021-06-30 | 65.63M shares 10-Q · filed 2021-08-05 | 65.62M shares 10-Q · filed 2021-08-05 | 65.43M shares derived: average of 3 quarters · filed 2022-05-05 | 64.64M shares derived: average of 4 quarters · filed 2022-05-05 |
| 2021-03-31 | 65.60M shares 10-Q · filed 2022-05-05 | 65.34M shares derived: average of 2 quarters · filed 2022-05-05 | 64.30M shares derived: average of 3 quarters · filed 2022-05-05 | 61.46M shares derived: average of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | 65.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | 63.65M shares derived: average of 2 quarters · filed 2022-03-08 | 60.08M shares derived: average of 3 quarters · filed 2022-03-08 | 53.37M shares 10-K · filed 2022-03-08 |
| 2020-09-30 | 62.24M shares 10-Q · filed 2021-11-04 | 57.59M shares derived: average of 2 quarters · filed 2021-11-04 | 49.47M shares 10-Q · filed 2021-11-04 | 45.32M shares derived: average of 4 quarters · filed 2022-03-08 |
| 2020-06-30 | 52.94M shares 10-Q · filed 2021-08-05 | 43.02M shares 10-Q · filed 2021-08-05 | 39.68M shares derived: average of 3 quarters · filed 2022-03-08 | 37.99M shares derived: average of 4 quarters · filed 2022-03-08 |
| 2020-03-31 | 33.10M shares 10-Q · filed 2021-05-10 | 33.05M shares derived: average of 2 quarters · filed 2022-03-08 | 33.00M shares derived: average of 3 quarters · filed 2022-03-08 | 32.96M shares derived: average of 4 quarters · filed 2022-03-08 |
| 2019-12-31 | 33.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | 32.95M shares derived: average of 2 quarters · filed 2022-03-08 | 32.91M shares derived: average of 3 quarters · filed 2022-03-08 | 31.95M shares 10-K · filed 2022-03-08 |
| 2019-09-30 | 32.89M shares 10-Q · filed 2020-11-05 | 32.87M shares derived: average of 2 quarters · filed 2020-11-05 | 31.60M shares 10-Q · filed 2020-11-05 | 29.68M shares derived: average of 4 quarters · filed 2021-03-18 |
| 2019-06-30 | 32.84M shares 10-Q · filed 2020-08-10 | 30.94M shares 10-Q · filed 2020-08-10 | 28.61M shares derived: average of 3 quarters · filed 2021-03-18 | 26.95M shares derived: average of 4 quarters · filed 2021-03-18 |
| 2019-03-31 | 29.01M shares 10-Q · filed 2020-05-07 | 26.49M shares derived: average of 2 quarters · filed 2021-03-18 | 24.99M shares derived: average of 3 quarters · filed 2021-03-18 | 23.89M shares derived: average of 4 quarters · filed 2021-03-18 |
| 2018-12-31 | 23.97M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | 22.98M shares derived: average of 2 quarters · filed 2021-03-18 | 22.19M shares derived: average of 3 quarters · filed 2021-03-18 | 20.82M shares 10-K · filed 2021-03-18 |
| 2018-09-30 | 21.99M shares 10-Q · filed 2019-11-06 | 21.29M shares derived: average of 2 quarters · filed 2019-11-06 | 19.77M shares 10-Q · filed 2019-11-06 | 18.96M shares derived: average of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | 20.60M shares 10-Q · filed 2019-08-06 | 18.65M shares 10-Q · filed 2019-08-06 | 17.95M shares derived: average of 3 quarters · filed 2020-02-24 | 17.57M shares derived: average of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | 16.67M shares 10-Q · filed 2019-05-07 | 16.63M shares derived: average of 2 quarters · filed 2020-02-24 | 16.56M shares derived: average of 3 quarters · filed 2020-02-24 | 15.95M shares derived: average of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | 16.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | 16.50M shares derived: average of 2 quarters · filed 2020-02-24 | 15.70M shares derived: average of 3 quarters · filed 2020-02-24 | 15.13M shares 10-K · filed 2020-02-24 |
| 2017-09-30 | 16.41M shares 10-Q · filed 2018-11-08 | 15.26M shares derived: average of 2 quarters · filed 2018-11-08 | 14.64M shares 10-Q · filed 2018-11-08 | 14.32M shares derived: average of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | 14.11M shares 10-Q · filed 2018-08-09 | 13.74M shares 10-Q · filed 2018-08-09 | 13.62M shares derived: average of 3 quarters · filed 2019-03-07 | 13.54M shares derived: average of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | 13.37M shares 10-Q · filed 2018-05-08 | 13.37M shares derived: average of 2 quarters · filed 2019-03-07 | 13.35M shares derived: average of 3 quarters · filed 2019-03-07 | 12.96M shares derived: average of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | 13.37M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | 13.35M shares derived: average of 2 quarters · filed 2019-03-07 | 12.82M shares derived: average of 3 quarters · filed 2019-03-07 | 9.79M shares 10-K · filed 2019-03-07 |
| 2016-09-30 | 13.33M shares 10-Q · filed 2017-11-07 | 12.55M shares derived: average of 2 quarters · filed 2017-11-07 | 8.60M shares 10-Q · filed 2017-11-07 | 6.59M shares derived: average of 4 quarters · filed 2018-03-13 |
| 2016-06-30 | 11.78M shares 10-Q · filed 2017-08-09 | 6.21M shares 10-Q · filed 2017-08-09 | 4.35M shares derived: average of 3 quarters · filed 2018-03-13 | 3.41M shares derived: average of 4 quarters · filed 2018-03-13 |
| 2016-03-31 | 640.70K shares 10-Q · filed 2017-05-09 | 633.76K shares derived: average of 2 quarters · filed 2018-03-13 | 626.81K shares derived: average of 3 quarters · filed 2018-03-13 | 616.56K shares derived: average of 4 quarters · filed 2018-03-13 |
| 2015-12-31 | 626.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | 619.87K shares derived: average of 2 quarters · filed 2018-03-13 | 608.51K shares derived: average of 3 quarters · filed 2018-03-13 | 599.79K shares 10-K · filed 2018-03-13 |
| 2015-09-30 | 612.92K shares 10-Q · filed 2016-11-09 | 599.36K shares derived: average of 2 quarters · filed 2016-11-09 | 590.77K shares 10-Q · filed 2016-11-09 | |
| 2015-06-30 | 585.80K shares 10-Q · filed 2016-08-09 | 579.52K shares 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | 573.17K shares 10-Q · filed 2016-05-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |